论文部分内容阅读
作者分析参加西华盛顿冠状动脉内链激酶溶栓治疗试验的245例(男性占86%)AMI患者的病史,入院当时临床心电图、心导管和造影资料,及其与一年存活率之间的关系.其中134例接受溶栓治疗,116例仅接受常规治疗.各例均无影响寿限的其它疾病且发病前无心力衰竭史.一年内存活217例;死亡28例:心脏性26例,可能心脏性1例,非心脏
The authors analyzed the medical history of 245 patients (86% of men) with AMI who participated in the Western Washington Thrombolysis Trial of coronary artery streptokinase, the clinical electrocardiogram, cardiac catheterization and contrast data at admission, and their relationship to one-year survival .There were 134 cases received thrombolytic therapy and 116 cases received routine treatment.Each case had no other disease which affected life expectancy and had no history of heart failure before onset.Their survival in 217 cases in one year.The death of 28 cases: 1 case of cardiac, non-cardiac